tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARTV Stock Latest News

Positive Buy Rating for Artiva Biotherapeutics, Inc. Driven by Promising AlloNK Cell Therapy Developments
RatingsPositive Buy Rating for Artiva Biotherapeutics, Inc. Driven by Promising AlloNK Cell Therapy Developments
18d ago
ARTV
Buy Rating Affirmed for Artiva Biotherapeutics Amid Promising AlloNK Data and Strong Financial Position
PremiumRatings
Buy Rating Affirmed for Artiva Biotherapeutics Amid Promising AlloNK Data and Strong Financial Position
18d ago
ARTV
Artiva Biotherapeutics files $300M mixed securities shelf
PremiumThe Fly
Artiva Biotherapeutics files $300M mixed securities shelf
19d ago
ARTV
Artiva Biotherapeutics Approves Equity Plan Amendment
PremiumCompany Announcements
Artiva Biotherapeutics Approves Equity Plan Amendment
2M ago
8K
ARTV
Promising Advancements and Financial Strength Position Artiva Biotherapeutics for Significant Upside
PremiumRatings
Promising Advancements and Financial Strength Position Artiva Biotherapeutics for Significant Upside
2M ago
ARTV
Artiva Biotherapeutics assumed with a Buy at H.C. Wainwright
PremiumThe FlyArtiva Biotherapeutics assumed with a Buy at H.C. Wainwright
3M ago
ARTV
Artiva Biotherapeutics announces new, long-term data for AlloNK combination
Premium
The Fly
Artiva Biotherapeutics announces new, long-term data for AlloNK combination
3M ago
ARTV
Artiva Biotherapeutics Reports Q1 2025 Progress
Premium
Company Announcements
Artiva Biotherapeutics Reports Q1 2025 Progress
4M ago
ARTV
Artiva Biotherapeutics: Strategic Delay and Expanded Research Justify Buy Rating
PremiumRatings
Artiva Biotherapeutics: Strategic Delay and Expanded Research Justify Buy Rating
4M ago
ARTV
Artiva Biotherapeutics, Inc.: Strategic Advancements and Market Potential in Biotherapeutics Highlighted by Phase IIa Trial Initiation and FDA Clearance
PremiumRatings
Artiva Biotherapeutics, Inc.: Strategic Advancements and Market Potential in Biotherapeutics Highlighted by Phase IIa Trial Initiation and FDA Clearance
4M ago
ARTV
Artiva Biotherapeutics reports Q1 EPS (83c) vs. ($17.24) last year
PremiumThe Fly
Artiva Biotherapeutics reports Q1 EPS (83c) vs. ($17.24) last year
4M ago
ARTV
Artiva Biotherapeutics sees cash runway into 2Q27
PremiumThe Fly
Artiva Biotherapeutics sees cash runway into 2Q27
4M ago
ARTV
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
BMY
ARTV
Artiva CMO Thorsten Graef switches to advisor role, Subhashis Banerjee succeeds
Premium
The Fly
Artiva CMO Thorsten Graef switches to advisor role, Subhashis Banerjee succeeds
5M ago
BMY
ARTV
Promising Outlook for Artiva Biotherapeutics Amid Strategic Manufacturing and Regulatory Support
Premium
Ratings
Promising Outlook for Artiva Biotherapeutics Amid Strategic Manufacturing and Regulatory Support
5M ago
ARTV
Artiva Biotherapeutics Reports 2024 Financial Results
PremiumCompany Announcements
Artiva Biotherapeutics Reports 2024 Financial Results
5M ago
ARTV
Artiva Biotherapeutics: Strong Buy Rating Backed by Promising Pipeline and Financial Stability
PremiumRatings
Artiva Biotherapeutics: Strong Buy Rating Backed by Promising Pipeline and Financial Stability
5M ago
ARTV
Artiva Biotherapeutics price target lowered to $20 from $23 at Cantor Fitzgerald
PremiumThe Fly
Artiva Biotherapeutics price target lowered to $20 from $23 at Cantor Fitzgerald
5M ago
ARTV
Artiva expands Board with appointment of Dan Baker, M.D
PremiumThe Fly
Artiva expands Board with appointment of Dan Baker, M.D
7M ago
CUE
JNJ
American Air upgraded, Nordstrom downgraded: Wall Street’s top analyst calls
PremiumThe FlyAmerican Air upgraded, Nordstrom downgraded: Wall Street’s top analyst calls
8M ago
AAL
JWN
Artiva Biotherapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Artiva Biotherapeutics initiated with a Buy at H.C. Wainwright
8M ago
ARTV
Affimed: Acimtamig, AlloNK combination granted RMAT designation by FDA
Premium
The Fly
Affimed: Acimtamig, AlloNK combination granted RMAT designation by FDA
9M ago
AFMD
ARTV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >